Physician profile
Pierre Jacques Botes
NPI 1124468541
$3,852.97
in general payments reported to CMS, 2019-2025
10 companies · $14.37 in 2025
The $14.37 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $362 · 2022: $39.89 · 2023: $553 · 2024: $2,680 · 2025: $14.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,356 · Food and Beverage: $766 · Gift: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,356.30 |
| Food and Beverage | $766.35 |
| Gift | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thommen Medical USA, LLC | $2,872.90 | 2023-2024 | |
| Straumann USA LLC | $305.15 | 2020-2024 | |
| A-Dec, INC. | $223.00 | 2019-2023 | |
| Dentsply Sirona INC | $167.50 | 2020-2023 | Tph3 Flow Liquid Micro Hybrid, Cavitron |
| Ultradent Products INC | $111.39 | 2024 | |
| Planmeca USA, INC. | $91.71 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $27.91 | 2022-2025 | |
| Philips North America LLC | $27.13 | 2022-2024 | (E55) Oral Health Care Und |
| Zimmer Biomet Holdings, INC. | $13.95 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Botes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.